Literature DB >> 32435548

Prototype Small-Animal PET-CT Imaging System for Image-guided Radiation Therapy.

Ekaterina Mikhaylova1, Jamison Brooks2,3, Darren Zuro2,3, Farouk Nouizi4, Maciej Kujawski5, Srideshikan Sargur Madabushi2, Jinyi Qi1, Mengxi Zhang1, Junie Chea6, Erasmus K Poku6, Nicole Bowles6, Jeffrey Y C Wong2, John E Shively5, Paul J Yazaki5, Gultekin Gulsen4, Simon R Cherry1, Susanta Hui2.   

Abstract

Molecular imaging is becoming essential for precision targeted radiation therapy, yet progress is hindered from a lack of integrated imaging and treatment systems. We report the development of a prototype positron emission tomography (PET) scanner integrated into a commercial cone beam computed tomography (CBCT) based small animal irradiation system for molecular-image-guided, targeted external beam radiation therapy. The PET component consists of two rotating Hamamatsu time-of-flight PET modules positioned with a bore diameter of 101.6 mm and a radial field-of-view of 53.1 mm. The measured energy resolution after linearity correction at 511 KeV was 12.9% and the timing resolution was 283.6 ps. The measured spatial resolutions at the field-of-view center and 5 mm off the radial center were 2.6 mm × 2.6 mm × 1.6 mm and 2.6 mm × 2.6 mm × 2.7 mm respectively. 18F-Fluorodeoxyglucose-based PET imaging of a NEMA NU 4-2008 phantom resolved cylindrical volumes with diameters as small as 3 mm. To validate the system in-vivo, we performed 64Cu-DOTA-M5A PET and computed tomography (CT) imaging of carcinoembryonic antigen (CEA)-positive colorectal cancer in athymic nude mice and compared the results with a commercially available Siemens Inveon PET/CT system. The prototype PET system performed comparably to the Siemens system for identifying the location, size, and shape of tumors. Regions of heterogeneous 64Cu-DOTA-M5A uptake were observed. Using 64Cu-DOTA-M5A PET and CT images, a Monte Carlo-based radiation treatment plan was created to escalate the dose to the 64Cu-DOTA-M5A-based, highly active, biological target volume while largely sparing the normal tissue. Results demonstrate the feasibility of molecular-image-guided treatment plans using the prototype theranostic system.

Entities:  

Keywords:  molecular imaging; multimodal imaging; targeted radiation; theranostic

Year:  2019        PMID: 32435548      PMCID: PMC7239319          DOI: 10.1109/access.2019.2944683

Source DB:  PubMed          Journal:  IEEE Access        ISSN: 2169-3536            Impact factor:   3.367


  19 in total

Review 1.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

Authors:  C C Ling; J Humm; S Larson; H Amols; Z Fuks; S Leibel; J A Koutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-06-01       Impact factor: 7.038

2.  Analytic and iterative reconstruction algorithms in SPECT.

Authors:  Philippe P Bruyant
Journal:  J Nucl Med       Date:  2002-10       Impact factor: 10.057

3.  Maximum likelihood reconstruction for emission tomography.

Authors:  L A Shepp; Y Vardi
Journal:  IEEE Trans Med Imaging       Date:  1982       Impact factor: 10.048

4.  Validating the sensitivity and performance of near-infrared fluorescence imaging and tomography devices using a novel solid phantom and measurement approach.

Authors:  B Zhu; I-C Tan; J C Rasmussen; E M Sevick-Muraca
Journal:  Technol Cancer Res Treat       Date:  2012-02

Review 5.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.

Authors:  Søren M Bentzen; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

6.  A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.

Authors:  Lin Li; James Bading; Paul J Yazaki; Amitkumar H Ahuja; Desiree Crow; David Colcher; Lawrence E Williams; Jeffrey Y C Wong; Andrew Raubitschek; John E Shively
Journal:  Bioconjug Chem       Date:  2007-11-08       Impact factor: 4.774

7.  The accuracy of EGSnrc, Geant4 and PENELOPE Monte Carlo systems for the simulation of electron scatter in external beam radiotherapy.

Authors:  Bruce A Faddegon; Iwan Kawrakow; Yuri Kubyshin; Joseph Perl; Josep Sempau; Laszlo Urban
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

8.  Humanization of the anti-CEA T84.66 antibody based on crystal structure data.

Authors:  Paul J Yazaki; Mark A Sherman; John E Shively; David Ikle; Lawrence E Williams; Jeffrey Y C Wong; David Colcher; Anna M Wu; Andrew A Raubitschek
Journal:  Protein Eng Des Sel       Date:  2004-08-17       Impact factor: 1.650

9.  PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.

Authors:  Aniek J G Even; Judith van der Stoep; Catharina M L Zegers; Bart Reymen; Esther G C Troost; Philippe Lambin; Wouter van Elmpt
Journal:  Radiother Oncol       Date:  2015-07-31       Impact factor: 6.280

10.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.

Authors:  Nancy Y Lee; James G Mechalakos; Sadek Nehmeh; Zhixiong Lin; Olivia D Squire; Shangde Cai; Kelvin Chan; Pasquale B Zanzonico; Carlo Greco; Clifton C Ling; John L Humm; Heiko Schöder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

View more
  1 in total

1.  Mobile bioluminescence tomography-guided system for pre-clinical radiotherapy research.

Authors:  Zijian Deng; Xiangkun Xu; Iulian Iordachita; Hamid Dehghani; Bin Zhang; John W Wong; Ken Kang-Hsin Wang
Journal:  Biomed Opt Express       Date:  2022-08-30       Impact factor: 3.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.